BTI
MRVI icon

Blue Trust Inc’s Maravai LifeSciences MRVI Stock Holding History

Blue Trust Inc’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,828
Closed -$4.04K – 2558
2025
Q1 		$4.04K Hold
1,828
– – ﹤0.01% 2136
2024
Q4 		$9.96K Sell
1,828
-15,581
-89% -$100K ﹤0.01% 1872
2024
Q3 		$125K Buy
17,409
+11,215
+181% +$96.9K ﹤0.01% 1097
2024
Q2 		$53.7K Buy
+6,194
New +$53.5K ﹤0.01% 1223
2024
Q1 		– Sell
-547
Closed -$5K – 2521
2023
Q4 		$5K Buy
+547
New +$3.53K ﹤0.01% 1850
2023
Q2 		– Sell
-15
Closed – – 2343
2023
Q1 		$0 Sell
15
-40
-73% -$574 ﹤0.01% 2508
2022
Q4 		$1K Buy
+55
New +$866 ﹤0.01% 2090

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Blue Trust Inc's MRVI Position: Q2 2025 in Review

Blue Trust Inc sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 1,828 shares — an estimated $4.04K sold.

Blue Trust Inc first reported a position in MRVI in Q4 2022 and held it in 7 quarters. The position peaked at $125K in Q3 2024. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • Blue Trust Inc reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Blue Trust Inc sold 1,828 Maravai LifeSciences shares in Q2 2025, an estimated $4.04K.
  • Blue Trust Inc first reported a position in Maravai LifeSciences in Q4 2022 and held it in 7 quarters.
  • Blue Trust Inc's Maravai LifeSciences position peaked at $125K in Q3 2024.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Blue Trust Inc's 13F filing for Q2 2025, filed 24 Jul 2025.